Total Funding
52
49
Total FundingSeries A raised
Growth Score
-4 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
57472
BioCentriq is a cell and gene therapy development and manufacturing center.
- David Smith: Vice President of Development
- Syed Husain: CEOPast Role: Resilience, Chief Commercial Officer
About the Company
BioCentriq is the cell and gene therapy development and manufacturing center. Leveraging state-of-the-art facilities, cutting-edge technologies, and a team of seasoned professionals, the company has a demonstrated history of effectively transferring, developing and manufacturing GMP drug products for clinical trial use. BioCentriq is committed to
driving innovation in cell therapy and assisting its partners in delivering transformative treatments to patients globally.
